logo

Genocea Biosciences, Inc. (GNCA)



Trade GNCA now with
  Date
  Headline
9/22/2020 7:37:10 AM Genocea: FDA Accepts GEN-011 IND Application
9/17/2020 3:15:56 AM Genocea Presents Follow-up Data From GEN-009 Neoantigen Vaccine Phase 1/2a Trial
5/19/2020 7:33:43 AM Genocea Enters Material Transfer And License Option Agreement With Shionogi For Proprietary GEN-003 HSV-2 Antigens